Applied Therapeutics (NASDAQ:APLT) just reported results for the first quarter of 2024.
- Applied Therapeutics reported earnings per share of -16 cents. This met the analyst estimate for EPS of -16 cents.
- The company reported revenue of $190,000.
- This was 94.29% worse than the analyst estimate for revenue of $3.33 million.